App aims to prevent pregnancy-related deaths in minority women
NCT ID NCT06415942
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study tests a smartphone app designed to help African American and Spanish-speaking patients recognize warning signs of pregnancy-related death. Participants choose symptoms they are having and get advice on when to call a doctor or go to the emergency room. The goal is to see if the app improves patients' ability to take charge of their health and increases knowledge of danger signs.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Maternal Outcome Monitoring and Support system (smartphone app)
- What this could lead to
- If successful, this app could help reduce pregnancy-related deaths by empowering patients to recognize warning signs and seek care sooner.
- What could go wrong
- This is a small, single-arm trial with 80 participants, so results may not apply broadly. The app's effectiveness depends on patient engagement and may not change outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
84 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Greater than 28 weeks pregnant * Receiving healthcare in the United States * Age 18 years or older * \[Identify as Black or African American race AND able to speak and read English, AND preferred language of English\] OR \[Identify as Hispanic/Latino Ethnicity AND Spanish able to speak and read Spanish AND preferred language of Spanish\] * Planned delivery at the following NewYork-Presbyterian hospitals: Children's Hospital of New York, Allen Hospital, Weill Cornell Medical Center, Lower Manhattan Hospital Exclusion Criteria: * Severe cognitive impairment * Major psychiatric illness * Concomitant terminal illness that would preclude participation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Maternal complication of pregnancy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NewYork-Prebyterian/Weill Cornell Medical Center
New York, New York, 10065, United States
-
NewYork-Presbyterian Columbia University Irving Medical Center
New York, New York, 10032, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.